Skip to main content
Erschienen in: PharmacoEconomics 10/2010

01.10.2010 | Methodological Considerations

No Head-to-Head Trial? Simulate the Missing Arms

verfasst von: Dr J.Jaime Caro, K. Jack Ishak

Erschienen in: PharmacoEconomics | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Establishing efficacy relative to placebo is no longer sufficient for payers to agree to cover new interventions. Evidence from comparisons of competing interventions is increasingly important, although head-to-head studies are seldom available to inform decisions. In this article, we describe the simulated treatment comparison (STC) approach to incorporating ‘missing arms’ into an existing trial. This approach yields a simulated head-to-head trial and can address many of the differences among source trials. It provides inputs for economic models and can inform decision makers until actual trial data are available.
A simulation is constructed to replicate an index trial, including enrolment, randomization and follow-up of patients. The simulation is driven by predictive equations derived from the index trial. Separate data for the comparators are used to calibrate the index equations to reflect the alternative interventions. The simulation is used to add the missing arms to the index trial and estimate the results that would have been obtained in a head-to-head trial. The STC can also be used to estimate results in various settings and populations and to explore variations in the trial design. An STC offers a way to derive comparative effectiveness in the absence of direct trial evidence and a platform to test design features that may help in planning future head-to-head studies.
Literatur
1.
Zurück zum Zitat Reinhardt UE. An information infrastructure for the pharmaceutical market. Health Aff (Millwood) 2004; 23 (1): 107–12CrossRef Reinhardt UE. An information infrastructure for the pharmaceutical market. Health Aff (Millwood) 2004; 23 (1): 107–12CrossRef
2.
Zurück zum Zitat Wilensky GR. Developing a center for comparative effectiveness information. Health Aff (Millwood) 2006; 25 (6): w572–85CrossRef Wilensky GR. Developing a center for comparative effectiveness information. Health Aff (Millwood) 2006; 25 (6): w572–85CrossRef
3.
Zurück zum Zitat Schneeweis S. Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 2007; 82: 143–56CrossRef Schneeweis S. Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 2007; 82: 143–56CrossRef
4.
Zurück zum Zitat Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290 (12): 1624–32PubMedCrossRef Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290 (12): 1624–32PubMedCrossRef
5.
Zurück zum Zitat Ades AE, Sculpher M, Sutton A, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006; 24 (1): 1–19PubMedCrossRef Ades AE, Sculpher M, Sutton A, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006; 24 (1): 1–19PubMedCrossRef
6.
Zurück zum Zitat Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23 (20): 3105–24PubMedCrossRef Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23 (20): 3105–24PubMedCrossRef
7.
Zurück zum Zitat Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21 (16): 2313–24PubMedCrossRef Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21 (16): 2313–24PubMedCrossRef
8.
Zurück zum Zitat Homocysteine Lowering Trialists’ Collaboration. Lowering blood homocysteine with folic acid based supplements:metaanalysis of randomised trials. BMJ 1998; 316 (7135): 894–8CrossRef Homocysteine Lowering Trialists’ Collaboration. Lowering blood homocysteine with folic acid based supplements:metaanalysis of randomised trials. BMJ 1998; 316 (7135): 894–8CrossRef
9.
Zurück zum Zitat Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899–909CrossRef Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899–909CrossRef
10.
Zurück zum Zitat Moore RA, McQuay HJ. Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69 (3): 287–94PubMedCrossRef Moore RA, McQuay HJ. Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69 (3): 287–94PubMedCrossRef
11.
Zurück zum Zitat Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327 (23): 1618–24PubMedCrossRef Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327 (23): 1618–24PubMedCrossRef
12.
Zurück zum Zitat Tugwell P, Knottnerus JA. Advantages of individual patient data analysis in systematic reviews. J Clin Epidemiol 2010; 63 (3): 233–4PubMedCrossRef Tugwell P, Knottnerus JA. Advantages of individual patient data analysis in systematic reviews. J Clin Epidemiol 2010; 63 (3): 233–4PubMedCrossRef
13.
Zurück zum Zitat Van Walraven C. Individual patient meta-analysis: rewards and challenges. J Clin Epidemiol 2010; 63 (3): 235–7PubMedCrossRef Van Walraven C. Individual patient meta-analysis: rewards and challenges. J Clin Epidemiol 2010; 63 (3): 235–7PubMedCrossRef
14.
Zurück zum Zitat Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005; 23 (4): 323–32PubMedCrossRef Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005; 23 (4): 323–32PubMedCrossRef
15.
Zurück zum Zitat Kelton WD, Sadowski RP, Sturrock DT, editors. Simulation with Arena. 4th ed. New York: McGraw-Hill, 2007 Kelton WD, Sadowski RP, Sturrock DT, editors. Simulation with Arena. 4th ed. New York: McGraw-Hill, 2007
16.
Zurück zum Zitat Caro JJ, Moller J, Getsios D. Discrete event simulation: the preferred technique for health economic evaluations? Value Health. In press Caro JJ, Moller J, Getsios D. Discrete event simulation: the preferred technique for health economic evaluations? Value Health. In press
17.
Zurück zum Zitat Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326 (7387): 472PubMedCrossRef Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326 (7387): 472PubMedCrossRef
18.
Zurück zum Zitat Ades AE, Lu G. Assessing evidence inconsistency in mixed treatment comparisons. JASA 2006; 101 (474): 447–59CrossRef Ades AE, Lu G. Assessing evidence inconsistency in mixed treatment comparisons. JASA 2006; 101 (474): 447–59CrossRef
19.
Zurück zum Zitat Ades AE, Lu G, Higgins JP. The interpretation of randomeffects meta-analysis in decision models. Med Decis Making 2005; 25 (6): 646–54PubMedCrossRef Ades AE, Lu G, Higgins JP. The interpretation of randomeffects meta-analysis in decision models. Med Decis Making 2005; 25 (6): 646–54PubMedCrossRef
Metadaten
Titel
No Head-to-Head Trial? Simulate the Missing Arms
verfasst von
Dr J.Jaime Caro
K. Jack Ishak
Publikationsdatum
01.10.2010
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 10/2010
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/11537420-000000000-00000

Weitere Artikel der Ausgabe 10/2010

PharmacoEconomics 10/2010 Zur Ausgabe